New Agents in Marginal Zone LymphomasNHLcopanlisibibrutinibmarginal zone lymphomaumbralisibzanubrutinibMarginal zone lymphomas (MZL) are indolent diseases with a heterogeneous presentation. Extranodal MZL of the mucosa-associated lymphoid tissue is the most common type, accounting for nearly 70% of all ...
Therefore, this study aimed to evaluate the roles of interim PET/CT in marginal zone lymphoma (MZL), a representative indolent lymphoma. We analyzed the data of 146 MZL patients. All were treated with rituximab-containing immunochemotherapy. Interim PET/CT scan was performed after 2–3 cycles ...
BACKGROUND:A retrospective review and analysis of 275 patients with marginal zone lymphoma (MZL) was performed to determine prognostic factors. An effort was also made to establish a specific prognostic score for patients with extranodal MZL.METHODS:Patients were divided into 3 groups according to ...
Marginal zone lymphoma (MZL) is an indolent non Hodgkin lymphoma (NHL) occurring in the setting of chronic antigenic stimulation such as Helicobacter pylori infections or Hepatitis C and may regress with treatment of the underlying infection. However, some may require treatment of the lymphoma with...
边缘区淋巴瘤(Marginal Zone Lymphomas,MZL)属于非霍奇金淋巴瘤中的惰性淋巴瘤,包括脾边缘区淋巴瘤(Splenic Marginal Zone Lymphomas,SMZL)、淋巴结边缘区淋巴瘤(Nodal Marginal Zone Lymphoma,NMZL)、黏膜相关淋巴组织淋巴瘤(Mucosa-associated Lymphoid Tissue,MALT)和结外边缘区淋巴瘤(Extranodal Marginal Zone Lymphoma...
Marginal zone lymphoma (MZL) is the third most common subtype of B-cell non-Hodgkin lymphoma. Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P=3.95 × 10−15) and HLA-B (rs2922994...
This entity has also been known as cutaneous marginal zone lymphoma (CMZL), extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MZL or MALT lymphoma), primary cutaneous immunocytoma, primary cutaneous plasmacytoma, and lymphoma cutis [1, 2]. This chapter will discuss the ...
Marginal zone lymphoma (MZL) is an indolent disease with a favorable prognostic outcome. MZLs account for 5–17% of all non-Hodgkin’s lymphomas (NHL) in adults. During the course of past years, the incidence of marginal zone lymphomas increased, caused by changes in diagnostic practice. MZ...
Introduction: Transformed marginal zone lymphoma (tMZL) is frequently included among diffuse large B cell lymphoma (DLBCL) cases and is treated in a similar manner. We aimed to define the prevalence of tMZL and compare treatment outcomes to those of patients with non‐transformed DLBCL treated ...
Marginal zone lymphoma (MZL) of the lung is an indolent B-cell lymphoma. The peripheral blood of most patients with pulmonary MZL contains low or undetectable monoclonal immunoglobulin (M protein) levels. In this case, the clinical laboratory discovered that the pulmonary MZL patient not only asso...